Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $61.44 USD
Change Today +0.27 / 0.44%
Volume 163.8K
ALKS On Other Exchanges
As of 11:08 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard F. Pops

Chairman of the Board and Chief Executive Officer,Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 157 board members in 10 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Richard F. Pops has been the Chief Executive Officer of Alkermes PLC since September 11, 2009. Mr. Pops founded Genomics Collaborative, Inc. He Co-Founded Sirtris Pharmaceuticals, Inc. He served as the President of Alkermes PLC from September 11, 2009 to September 16, 2011 and previously served as its Chief Executive Officer from February 1991 to April 1, 2007. Prior to Alkermes, he was employed by PaineWebber Development Corporation as a Vice President. He has been ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4


Phone: 353 1 772 8000
Fax: --

Board Members Memberships*

Director At Large
Chairman of the Board and Chief Executive Officer
Independent Director, Chairman of Compensation Committee and Member of Audit Committee
Director and Member of Nominating & Corporate Governance Committee
Independent Director and Member of Audit Committee


BA 1983
Stanford University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$854,716

Stock Options*

Restricted Stock Awards$2,452,320
All Other Compensation$13,000
Exercised Options500,000
Exercised Options Value$17,602,025
Exercisable Options2,366,250
Exercisable Options Value$105,028,888
Unexercisable Options780,000
Unexercisable Options Value$21,708,750
Total Value of Options$144,339,662
Total Number of Options3,646,250

Total Compensation*

Total Annual Cash Compensation$2,581,716
Total Short Term Compensation$854,716
Other Long Term Compensation$2,465,320
Total Calculated Compensation$10,448,380
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALKS:US $61.36 USD +0.19


David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee
Emergent BioSolutions, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at